Sanofi SA (SAN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

€82.27

Buy

€82.82

arrow-up€0.28 (+0.34%)

Prices updated at 19 Dec 2025, 17:21 CET

Prices minimum 15 mins delay

Prices in EUR

Sanofi SA is healthcare company which is engaged in the research, development, manufacture and marketing of therapeutic solutions. It business activities include operations of specialty care, Established Prescription Products and vaccines operations.

FTSE EuroFirst 300

0.43%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Mr. Frederic Oudea

CEO

Mr. Paul Hudson

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

82,878

Head office

46, Avenue de la Great Army

Paris

France

75017

+33 153774000

investor.relations@sanofi.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Francois-Xavier Roger Executive Vice President and Chief Financial Officer	-
Ms. Lise Kingo Independent Director	0.17m
Mr. Olivier Charmeil Executive Vice President, General Medicines	-
Mr. Paul Hudson Director and Chief Executive Officer	1.30m
Ms. Fabienne Lecorvaisier Independent Director	0.17m
Mr. Patrick Kron Independent Director	0.20m
Mr. Frederic Oudea Chairman of the Board	-
Ms. Anne-Francoise Nesmes Independent Director	0.12m
Mr. Jean-Paul Kress, M.D. Independent Director	-
Mr. Christophe Babule Director	0.16m
Mr. John Sundy Independent Director	0.11m
Ms. Rachel Duan Independent Director	0.15m
Ms. Carole Ferrand Independent Director	0.20m
Dr. Antoine Yver, M.D.,M.Sc. Independent Director	0.18m
Ms. Natalie Bickford Executive Vice President and Chief People Officer	-
Ms. Julie Van Ongevalle Executive Vice President, Consumer Healthcare	-
Mr. Thomas Triomphe Executive Vice President, Vaccines	-
Ms. Clotilde Delbos Independent Director	0.12m
Mr. Brendan O'Callaghan Executive Vice President, Global Manufacturing and Supply	-
Mr. Roy Papatheodorou Executive Vice President and General Counsel	-
Mr. Wolfgang Laux Director	0.13m
Ms. Barbara Lavernos Director	0.16m
Mr. Yann Tran Director	0.11m
Mr. Emile Voest Independent Director	0.16m
Ms. Madeleine Roach Executive Vice President, Business Operations	-
Mr. Emmanuel Frenehard Executive Vice President and Chief Digital Officer	-
Mr. Brian Foard Executive Vice President, Specialty Care	-
Mr. Houman Ashrafian Executive Vice President and Head of Research and Development	-
Ms. Audrey Duval Executive Vice President, Corporate Affairs	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Capital Research and Management Company	44,202,019
Vanguard Group Inc	33,647,710
BlackRock Fund Advisors	22,534,797
Dodge & Cox	17,537,204
Vanguard Total Intl Stock Idx Fund	15,664,651

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.